Get informed when a big investor buys or sells
+ Follow-0.46
The PEG ratio measures a stock's valuation relative to its earnings growth rate. A PEG ratio below 1.0 may indicate that the stock is undervalued relative to its growth potential.
The latest PEG ratio for COEP is -0.46. That is below the sector sector average of -0.06. Investors often review this figure alongside Coeptis Therapeutics Holdings's historical trend and sector peers before judging valuation or financial health.
Against its sector companies, COEP currently prints -0.46 for PEG ratio, while the sector average sits near -0.06. That is roughly 690.5% below the sector mean. Large gaps often invite a closer look at Coeptis Therapeutics Holdings's growth, margins, and balance sheet.
A PEG ratio of -0.46 for Coeptis Therapeutics Holdings is not 'good' or 'bad' on its own. Compare it with the peer average (-0.06) and with COEP's multi-year chart on this page. Persistently elevated multiples need growth or quality to justify them; depressed multiples need a catalyst or evidence the business is misunderstood.
After noting COEP's PEG ratio (-0.46), review year-over-year change, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.